Premium
CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?
Author(s) -
Lee Cindy,
Guinn Barbaraann,
Brooks Suzanne E.,
Richardson Deborah,
Orchard Kim
Publication year - 2010
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2010.08100.x
Subject(s) - biology , carcinoembryonic antigen , microbiology and biotechnology , bone marrow , antigen , myeloid , immunology , cancer research , genetics , cancer